Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor α degradation Journal Article


Authors: Lallemand-Breitenbach, V.; Zhu, J.; Puvion, F.; Koken, M.; Honoré, N.; Doubeikovsky, A.; Duprez, E.; Pandolfi, P. P.; Puvion, E.; Freemont, P.; De Thé, H.
Article Title: Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor α degradation
Abstract: Promyelocytic leukemia (PML) is the organizer of nuclear matrix domains, PML nuclear bodies (NBs), with a proposed role in apoptosis control. In acute promyelocytic leukemia, PML/retinoic acid receptor (RAR) α expression disrupts NBs, but therapies such as retinoic acid or arsenic trioxide (As2O3) restore them. PML is conjugated by the ubiquitin-related peptide SUMO-1, a process enhanced by As2O3 and proposed to target PML to the nuclear matrix. We demonstrate that As2O3 triggers the proteasome-dependent degradation of PML and PML/RARα and that this process requires a specific sumolation site in PML, K160. PML sumolation is dispensable for its As2O3-induced matrix targeting and formation of primary nuclear aggregates, but is required for the formation of secondary shell-like NBs. Interestingly, only these mature NBs harbor 11S proteasome components, which are further recruited upon As2O3 exposure. Proteasome recruitment by sumolated PML only likely accounts for the failure of PML-K160R to be degraded. Therefore, studying the basis of As2O3-induced PML/RARα degradation we show that PML sumolation directly or indirectly promotes its catabolism, suggesting that mature NBs could be sites of intranuclear proteolysis and opening new insights into NB alterations found in viral infections or transformation.
Keywords: leukemia; mutation; interferon; nonhuman; ubiquitin; animal cell; mouse; animals; mice; cells, cultured; apoptosis; proteasome; proteasome endopeptidase complex; models, biological; protein degradation; neoplasm proteins; cell line; transcription factors; nuclear proteins; arsenicals; oxides; tumor suppressor proteins; protein transport; promyelocytic leukemia; cell nucleus; sumo-1 protein; adenosine triphosphatases; protein isoforms; amino acid motifs; ubiquitins; endopeptidases; cho cells; cricetinae; retinoic acid receptor; arsenic; receptors, retinoic acid; cell nucleus inclusion body; cell nucleus matrix; nuclear matrix; priority journal; article
Journal Title: Journal of Experimental Medicine
Volume: 193
Issue: 12
ISSN: 0022-1007
Publisher: Rockefeller University Press  
Date Published: 2001-06-18
Start Page: 1361
End Page: 1371
Language: English
DOI: 10.1084/jem.193.12.1361
PUBMED: 11413191
PROVIDER: scopus
PMCID: PMC2193303
DOI/URL:
Notes: Export Date: 21 May 2015 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors